These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25462173)

  • 1. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
    Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
    Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
    Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
    Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
    Huelsenbeck J; Henninger C; Schad A; Lackner KJ; Kaina B; Fritz G
    Cell Death Dis; 2011 Aug; 2(8):e190. PubMed ID: 21833028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.
    Tocchetti CG; Carpi A; Coppola C; Quintavalle C; Rea D; Campesan M; Arcari A; Piscopo G; Cipresso C; Monti MG; De Lorenzo C; Arra C; Condorelli G; Di Lisa F; Maurea N
    Eur J Heart Fail; 2014 Apr; 16(4):358-66. PubMed ID: 24464789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
    Shaker RA; Abboud SH; Assad HC; Hadi N
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin.
    Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X
    Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
    Zhang YY; Yi M; Huang YP
    Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
    Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
    Grant MK; Seelig DM; Sharkey LC; Zordoky BN
    Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
    Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
    Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
    Pecoraro M; Del Pizzo M; Marzocco S; Sorrentino R; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
    Toxicol Appl Pharmacol; 2016 Feb; 293():44-52. PubMed ID: 26780402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
    Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
    Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
    Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
    Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fermented Cordyceps sinensis on doxorubicin‑induced cardiotoxicity in rats.
    Wu R; Yao PA; Wang HL; Gao Y; Yu HL; Wang L; Cui XH; Xu X; Gao JP
    Mol Med Rep; 2018 Sep; 18(3):3229-3241. PubMed ID: 30066944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
    Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
    Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis.
    Qin D; Yue R; Deng P; Wang X; Zheng Z; Lv M; Zhang Y; Pu J; Xu J; Liang Y; Pi H; Yu Z; Hu H
    Biomed Pharmacother; 2021 Aug; 140():111779. PubMed ID: 34062415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.